DaVita
DVA
#1886
Rank
S$13.30 B
Marketcap
S$198.99
Share price
-1.49%
Change (1 day)
-1.99%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.09

According to DaVita's latest financial reports the company's current EPS (TTM) is S$13.04. In 2024 the company made an earnings per share (EPS) of S$14.21 an increase over its 2023 EPS that were of S$9.81.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.09-7.87%
2024S$14.2144.94%
2023S$9.8127.26%
2022S$7.71-35.56%
2021S$11.9644.1%
2020S$8.3019.7%
2019S$6.93540.48%
2018S$1.08-76.07%
2017S$4.52-19.31%
2016S$5.61242.52%
2015S$1.64-62.87%
2014S$4.4113.43%
2013S$3.888.45%
2012S$3.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$30.24 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.57 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$18.94 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.45-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA